Organizational restructuring of Biofrontera and resignation of Chief Commercial Officer Christoph Dünwald
January 31, 2020 11:38 ET
|
Biofrontera AG
Leverkusen, Germany, Jan. 31, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...